Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
For Tectonic obviously.
I’d love an open and honest Q&A with Allan but it does seem as though he wants to keep info to a minimum and low profile.
The reason ? I hope because we are on 2 year or less countdown to Launching First commercial Test to Market.
5 mins 25 onwards Allan discusses Placing is being used directly to support the journey of Test to Market and discusses 4 key steps.
He states Success !!!! Last 6 month re developing Monoclonal antibodies - essential to detect the Ciz1b Bio marker.
Step 1 6 mins Allan says NOW ready for scale up phase (Must be Photeogenix deal (No previous RNS) and refers to going into Clinical Trials defo in USA with THE NEW COMMERCIAL ANTIBODY” (I assume this after scale up) and says “Pretty straight forward task” at 6 mins 38 sec.
Now … Does he mean
Straight Forward Task of Scale Up or..
IF Scale up is success then going to Trials (Stage 2) is Straight Forward Task ?
Probably the latter but interpretation is ambiguous.
If he is quoting any association with the short sentence of “Straight forward Task” with Stage 1 then each Stage carries Risk / so is he committing to slam dunk Stage 1 or merely IF Stage 1 Scale up successful / then moving to Stage 2 ie Trials is Slam dunk ?
Hope this clarifies my point. His communication is open to interpretation imo.
Re Allan. He appears to me (and just my opinion), that he held back and read almost robotically from a script in Directors Talk - was very careful not to branch off re various obvious Questions that were never asked. Now … One could say they are just buying time as product won’t make it to market .. Or One could say he comes across as not wanting to attract PI money and thus keep SP low to let those on the inside in - by avoiding obvs demand for Private Investor Q and A.
Personally i think Allan sailing close to the wind re recent RNS and subsequent low profile. So the real Question is why ? Either we are close (Inside 2 years to Market) or Widglide is right or partially right.
All about opinion. I hasten to add / not helped by Alan’s current low profile..
Widglide. A Vaccine for Lung Cancer ? Who’s gonna take that without knowing they actually have Lung Cancer ? Don’t you think they’d take a screening Test first before admission ? Once you’d taken the Test, and if positive, you’d take any needle offered, but not beforehand. The only hope is early detection. There hasn’t been a cure for anything from Big Pharma in the last 60 years. People still get COVID despite Global mass Vaccination program.
Or you maybe right ? They may be struggling with where they stand with the product. But what’s your evidence of this other than dotting the i’s.
In Directors Talk / Allan confirmed there were 4 key stages to accomplish route to Market but did not offer any Timeline. Nor did the Host ask any Timeline Questions. The Interview was staged / felt like it had been called at short notice by Allan himself. There was nothing genuine about it imo. Completely unprofessional and repetitive gargle. Pointless. After 6 months of abyss.
10 Aug RNS “The recent developments meet key milestones to begin commercial clinical trials. The Company is now engaged in clinical trials design to support the validation and accreditation of the CIZ1B test prior to commercial launch”.
So, between then and recent RNS some critical information has been held back / failed to notify the Market as we are now not ready for Critical Trials / although Allan in Directors Talk states this is a formality / inferring it’s a slam dunk (Correct me if I’m wrong I can go back to the minutes and seconds if necessary.
Allan has also failed to explain the reason for change in direction re the Finance and this has had a clear effect on the SP.
He’s states we have”New Shareholders” re this change of Financing so why would they Invest anything unless they knew more than the RNS ?
All in all there is more than a sniff of suspicion that Allan continues to withhold information that would no doubt have a material effect on SP if he notified Market. Positive or Negative / remains to be seen. Proof already registered as Negative to SP re intension to change Finance structure.
Apologies if this merely Repeats what has been said / I am just catching up and using this as a Marker to refer back to.
Why has Allan switched to Novum securities when he hasn’t drawn down any (Any ?? Zero ??) of the £500k fund.
The answer must be that whoever behind the vehicle - Novum / has promised more funding down the line should it be required. So prepare for 2p super low price access until Cizz get to production ?
They only raise enough to keep going 6 month … Don’t they ??
Really disappointed Allan didn’t RNS where Cizzle fits into the Cancer battle / structure of things after the BBC specifically named Lung Cancer breakthrough yesterday. However ; it seemed to me that the “Breakthrough” was ability in detecting Defecting genes once the Tumor was present / so hopefully our goal is to identify much earlier than that - but would be ideal opportunity for Allan to inform his Shareholders where we fit in the grand scheme. Radio silence continueth.
As prev stated. I doubt they will make the £100 Target due to recent Global Inflation. However ; the overriding goal is clearly to deliver a low cost price so that maximum tests can be utilised and thus eradicate Lung to a minimum. The only way to do this is to catch it early and continue regular testing to those at risk.
“Lung cancer is often curable if caught while still contained in your lung. Lung cancer that has spread beyond your lung isn't usually considered curable. The American Cancer Society estimates that there were approximately 236,740 new lung cancer cases in the United States in 2022. Jan 2023”.
And good of you to offer detailed opinion Greend100. This is what a bb is all about. Helps us adjust our own ideas and corroborate and come to some sort of consensus which is hopefully more accurate than when we first spoke.